173 related articles for article (PubMed ID: 35780678)
1. Indices of iron homeostasis in asymptomatic subjects with HFE mutations and moderate ferritin elevation during iron removal treatment.
Infanti L; Leitner G; Moe MK; Pehlic V; Benkert P; Cattaneo M; Holbro A; Passweg J; Worel N; Buser A
Blood Cells Mol Dis; 2022 Nov; 97():102689. PubMed ID: 35780678
[TBL] [Abstract][Full Text] [Related]
2. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
[TBL] [Abstract][Full Text] [Related]
3. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.
Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP
Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080
[TBL] [Abstract][Full Text] [Related]
4. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis.
Girelli D; Trombini P; Busti F; Campostrini N; Sandri M; Pelucchi S; Westerman M; Ganz T; Nemeth E; Piperno A; Camaschella C
Haematologica; 2011 Apr; 96(4):500-6. PubMed ID: 21173098
[TBL] [Abstract][Full Text] [Related]
5. The hepcidin gene promoter nc.-1010C > T; -582A > G haplotype modulates serum ferritin in individuals carrying the common H63D mutation in HFE gene.
Silva B; Pita L; Gomes S; Gonçalves J; Faustino P
Ann Hematol; 2014 Dec; 93(12):2063-6. PubMed ID: 25015054
[TBL] [Abstract][Full Text] [Related]
6. Significance of H63D homozygosity in a Basque population with hemochromatosis.
Castiella A; Zapata E; de Juan MD; Otazua P; Fernandez J; Zubiaurre L; Arriola JA;
J Gastroenterol Hepatol; 2010 Jul; 25(7):1295-8. PubMed ID: 20594259
[TBL] [Abstract][Full Text] [Related]
7. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes.
Raddatz D; Legler T; Lynen R; Addicks N; Ramadori G
Z Gastroenterol; 2003 Nov; 41(11):1069-76. PubMed ID: 14648375
[TBL] [Abstract][Full Text] [Related]
8. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
[TBL] [Abstract][Full Text] [Related]
9. Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins.
Whitfield JB; Cullen LM; Jazwinska EC; Powell LW; Heath AC; Zhu G; Duffy DL; Martin NG
Am J Hum Genet; 2000 Apr; 66(4):1246-58. PubMed ID: 10739755
[TBL] [Abstract][Full Text] [Related]
10. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
Pedersen P; Milman N
Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
[TBL] [Abstract][Full Text] [Related]
11. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
12. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.
Velati C; Marlianici E; Rigamonti D; Barillari G; Chiavilli F; Fugiani P; Garozzo G; Lancieri M; Rinaldi S; Testa D; Sampietro M; Tavazzi D; Delbini P; Fargion S; Fiorelli G
Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of hemochromatosis-related HFE C282Y/H63D gene mutations in patients on chronic dialysis.
Canavese C; Bergamo D; Barbieri S; Timbaldi M; Thea A; Martina G; Damiani D; Fenoglio R; Donati-Marella B; Priolo G
Clin Nephrol; 2002 Dec; 58(6):438-44. PubMed ID: 12508966
[TBL] [Abstract][Full Text] [Related]
14. Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis.
Piperno A; Girelli D; Nemeth E; Trombini P; Bozzini C; Poggiali E; Phung Y; Ganz T; Camaschella C
Blood; 2007 Dec; 110(12):4096-100. PubMed ID: 17724144
[TBL] [Abstract][Full Text] [Related]
15. Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain.
Aranda N; Viteri FE; Montserrat C; Arija V
Ann Hematol; 2010 Aug; 89(8):767-73. PubMed ID: 20107990
[TBL] [Abstract][Full Text] [Related]
16. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism.
Njajou OT; Houwing-Duistermaat JJ; Osborne RH; Vaessen N; Vergeer J; Heeringa J; Pols HA; Hofman A; van Duijn CM
Eur J Hum Genet; 2003 Mar; 11(3):225-31. PubMed ID: 12673276
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients.
Phatak PD; Ryan DH; Cappuccio J; Oakes D; Braggins C; Provenzano K; Eberly S; Sham RL
Blood Cells Mol Dis; 2002; 29(1):41-7. PubMed ID: 12482402
[TBL] [Abstract][Full Text] [Related]
18. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study.
Barton JC; Acton RT; Dawkins FW; Adams PC; Lovato L; Leiendecker-Foster C; McLaren CE; Reboussin DM; Speechley MR; Gordeuk VR; McLaren GD; Sholinsky P; Harris EL
Genet Test; 2005; 9(3):231-41. PubMed ID: 16225403
[TBL] [Abstract][Full Text] [Related]
19. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.
Nelson JE; Brunt EM; Kowdley KV;
Hepatology; 2012 Nov; 56(5):1730-40. PubMed ID: 22611049
[TBL] [Abstract][Full Text] [Related]
20. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
